Enter your terms above and click the 'Search' button.

Showing articles 0 to 3 of 3 Filter Applied: central nervous system,infection of (Click to remove) Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies JAMA Neurol 77:184-191, Luna, G.,et al, 2020 Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009 Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab NEJM 353:375-381, Langer-Gould,A.,et al, 2005 Showing articles 0 to 3 of 3